Luminate Medical
PrivateLast Round
Series A
Extension
Jan 7, 2026
Est. Valuation
$78M
Total Funding Raised
$68.94M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Luminate Medical operates in Healthcare & Life Sciences and is based in Ireland. Its latest recorded funding round was a Series A Extension round in January 2026.
Luminate Medical is a medical technology company that develops wearable devices and services to prevent chemotherapy side effects and enable at-home cancer care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine, Clinical Trials
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Luminate Medical Comparables
Compare Luminate Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cooler Heads Care | 90% | |
| Paxman AB | 83% | |
| Penguin Cold Caps | 74% |
For institutional investors. Book with your work email.
Luminate Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 7, 2026 | ||||
| Grant | Apr 23, 2025 | ||||
| Series A Extension | Dec 4, 2024 | ||||
| Series A | Sep 19, 2024 | ||||
| Grant | Nov 23, 2023 | ||||
Grant | Jun 20, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Luminate Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Atlantic Bridge Capital | Series A Extension, Series A |
| European Innovation Council Fund | Grant |
| Gaingels | Series A |
| ARTIS Ventures | Series A Extension, Series A |
| Y Combinator | Accelerator, Series A Extension |
| Faber Ventures | Series A Extension, Series A, Seed |
| Elkstone | Series A Extension, Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2026
Grew 24% QoQ, from 50 to 62 employees.
- Apr 23, 2026
Grew 16% QoQ from 51 to 59 employees.
For institutional investors. Book with your work email.
Luminate Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Luminate Medical's valuation, stock price, and market status.
Is Luminate Medical a public or private company?
Luminate Medical is a private company.
What is the current stock price of Luminate Medical?
Luminate Medical is a private company, so its shares have no public market price. Caplight tracks Luminate Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Luminate Medical worth (valuation)?
Luminate Medical's valuation is estimated at $78.0M based on funding round data.
Can I buy Luminate Medical stock?
Luminate Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Luminate Medical's last funding round?
Luminate Medical's most recent funding round was Series A Extension on January 7, 2026.
Who are the main investors in Luminate Medical?
Key investors in Luminate Medical include Atlantic Bridge Capital, ARTIS Ventures, Elkstone, SciFounders.
Will Luminate Medical IPO soon?
No public IPO plans have been announced for Luminate Medical.
How can I track Luminate Medical secondary market activity?
Caplight tracks bids, offers, and trades in Luminate Medical's shares on secondary markets.